Simnova Biotherapeutics

Simnova Biotherapeutics

  • Founded: 2019
  • Location: Shanghai, China
  • Employee range: 50 - 200
  • Clinical stage: Clin2
  • Therapy area: MM
  • Drug types: ONC
  • Lead product: SNC102
  • Product link:
  • Funding: not disclosed

job board

Short description:

CAR-NK & CAR-T Cell Therapy

Drug notes:

SNC103 Clin0 B-cell malignancies; SNC109 Clin0 Glioblastoma multiforme; 4 add'l product RD

Long description:

Simnova Biotherapeutics is developing cell therapies to treat cancer. Using cutting-edge technologies and platforms, Simnova is primarily focusing on the development of CAR-T cell therapies for oncology, including hematological malignancy and solid tumors. Simnova has a deep knowledge of tumor immunobiology and is also exploring the development of oncolytic viruses, next generation cytokines and cancer vaccines, some of which are in preclinical studies. Meanwhile, initial CAR-T candidates have entered clinical studies for cancer patients.


Simnova Biotherapeutics
Shanghai, China|100+ days ago

© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy